[1]
“Capecitabine-Induced Subacute Cutaneous Lupus Erythematosus in a Patient with Systemic Lupus Erythematosus”, J of Skin, vol. 2, no. 1, pp. 59–63, Jan. 2018, doi: 10.25251/skin.2.1.9.